Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Accumulated Expenses (2022 - 2025)

Prokidney (PROK) has disclosed Accumulated Expenses for 4 consecutive years, with $26.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Accumulated Expenses rose 22.59% to $26.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $26.1 million, a 22.59% increase, with the full-year FY2024 number at $31.1 million, up 76.26% from a year prior.
  • Accumulated Expenses was $26.1 million for Q3 2025 at Prokidney, up from $24.9 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $31.1 million in Q4 2024 to a low of $5.3 million in Q1 2022.
  • A 4-year average of $16.4 million and a median of $15.5 million in 2023 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: surged 175.48% in 2023, then decreased 27.86% in 2024.
  • Prokidney's Accumulated Expenses stood at $7.3 million in 2022, then surged by 140.8% to $17.7 million in 2023, then soared by 76.26% to $31.1 million in 2024, then dropped by 16.28% to $26.1 million in 2025.
  • Per Business Quant, the three most recent readings for PROK's Accumulated Expenses are $26.1 million (Q3 2025), $24.9 million (Q2 2025), and $27.6 million (Q1 2025).